ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Adalimumab & Infliximab Remain in Newborns after Delivery

Michele B. Kaufman, PharmD, BCGP  |  June 15, 2016

A recent study showed that, when administered during pregnancy, infliximab takes longer to clear an infant’s system than adalimumab…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabAnti-TNFinflammatory bowel diseaseinfliximabpregnancy

How to Deliver Difficult News about Patients' Diagnoses

How to Deliver Difficult News about Patients’ Diagnoses

Karen Appold  |  July 14, 2015

Telling a patient that he or she has been diagnosed with rheumatoid arthritis (RA), ankylosing spondylitis, fibromyalgia or another debilitating, painful and/or chronic condition can be upsetting for a patient to hear and difficult for a rheumatologist to convey. Given this, it’s important to prepare for the appointment. “Take a few minutes beforehand to contemplate…

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:chronic conditionDiagnosispatient carephysicianrheumatologist

Prior Authorization Requests Delay or Prevent Delivery of Needed Meds

Richard Quinn  |  March 27, 2015

Rheumatologist denounces common practice as a time-draining impediment to patient care

Filed under:Practice Support Tagged with:Health InsuranceMedicationpatient carePractice Managementprior authorizationrheumatologist

Nanoparticle Medicine Delivery Shows Promise

Kurt Ullman  |  June 13, 2013

Researchers treated mouse model of systemic lupus erythematous with mycophenolic acid delivered via nanoparticle. (posted June 18, 2013)

Filed under:Drug Updates Tagged with:LupusNanoparticleSLE

Electronic Prescribing: The First Step Towards an Integrated Health Delivery System?

Staff  |  February 1, 2009

With the introduction of the 2009 Centers for Medicare and Medicaid Services’ (CMS’s) electronic prescribing incentive program, the door is opening for widespread adoption of health information technology (HIT) within the physician’s practice.

Filed under:From the CollegePractice Support Tagged with:Practice Tips

Arthritis Care & Research Now Has 2 Editors in Chief

Leslie Mertz, PhD  |  December 12, 2025

Following a five-year term as editor in chief of Arthritis Care & Research (AC&R), Kelli Allen, PhD, is beginning another five-year stint with the journal, but now as co-editor in chief (co-EiC) with Daniel K. White, PT, ScD, who had formerly served as an AC&R associate editor. Dr. Allen is professor of medicine in the…

Filed under:CareerCareer DevelopmentFrom the CollegeProfiles Tagged with:AC&RArthritis Care & ResearchDaniel K. WhiteDr. Kelli AllenMentorshipPeer review

Expanding Lupus Awareness through Education

Collaborative Initiatives Department Staff  |  December 12, 2025

With funding support from the CDC, in this ACR initiative, rheumatology fellows in training deliver lupus education sessions to medical personnel & rheumatologists connect with medical colleagues in underserved rural areas.

Filed under:CareerConditionsEducation & TrainingSystemic Lupus Erythematosus Tagged with:Centers for Disease Control and PreventionCollaborative Initiatives Committee (COIN)Fellows-in-TrainingThe Lupus Initiative

Prednisone or Methotrexate for Pulmonary Sarcoidosis?

Deborah Levenson  |  December 11, 2025

The recently released PREDMETH study results indicate that methotrexate can be considered a real alternative to prednisone for patients with pulmonary sarcoidosis.

Filed under:Biologics/DMARDsConditionsDrug UpdatesOther Rheumatic ConditionsResearch Rheum Tagged with:CorticosteroidsMethotrexateprednisonepulmonary sarcoidosisSarcoidosis

The Promise of Hope in Lupus Nephritis

Colin B. Ligon, MD, MHS  |  December 9, 2025

Explore the latest lupus nephritis advances in this supplement, covering CAR-T therapy, obinutuzumab data & new diagnostic tools.

Filed under:ConditionsOpinionRheuminationsSystemic Lupus Erythematosus Tagged with:B cellsCAR-T cell therapyDubois Memorial LectureLupus nephritis supplementobinutuzumab

Reflections on B Cells in SLE & Lupus Nephritis

Ruth Jessen Hickman, MD  |  December 5, 2025

At the Dubois Memorial Lecture presented at ACR Convergence 2025, Shaun Jackson, MD, PhD, discussed the evolving understanding of the role of B cells in SLE.

Filed under:ACR ConvergenceMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2025ACR Convergence 2025 - LNLupusLupus nephritis supplementsystemic lupus erythematosus (SLE)

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 130
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences